IQInvest research note
12 OCT 2026 · 06:10 ET
BSX
Boston Scientific Corporation
$42.73
$0.69 (+1.64%)up 1.64%
12 October 2026 · delayed 15+ min
F
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Boston Scientific Corporation earns a F on good profit margins (>10%) and positive free cash flow but high debt-to-equity ratio (>2.0) and price well below 200-day SMA (downtrend). Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these
IQ-BSX-20261012engine v1 · 7-category weighted scorecard